Journal Home
Search for

Volume 18, Issue 2, Pages 167-186 (March 2008)


View previous. 6 of 27 View next.

Protein Restriction and Body Composition in Renal Disease

Sintra Eyre, RDCorresponding Author Informationemail address, Per-Ola Attman, MD, PhD

Objective

To study the effect of low-protein diet (LPD) on body composition (BC).

Study Design

A systematic review of the literature investigating BC during LPD treatment using total body potassium, dual energy X-ray absorptiometry, bioelectrical impedance analysis, and anthropometry.

Patients

Studies reporting data of patients treated with LPD 0.3–0.75 g/kg/day and a renal function of glomerular filtration rate (GFR) ≤20 mL/min, creatinine clearance ≤25 mL/min, on serum creatinine ≥500 μmol/L were included in the review. Fourteen studies with a total number of 666 subjects were found eligible.

Results

All studies except two concluded that treatment with LPD does not affect BC negatively. However, LPD should not be introduced in patients with a complicating disease, e.g., acidosis, septicaemia, and surgical treatment; neither should it be continued in patients who are unable to adhere to a diet prescription. Furthermore, LPD should be introduced with great caution in patients with an expected time to dialysis of ≤4 months due to an initial reduction of body weight and/or fat-free mass. Monitoring of treatment with LPD must be emphasized, including BC measurements and evaluation of protein and energy intake. These conclusions do not apply to patients with diabetes mellitus, because this diagnosis was excluded in a majority of reviewed studies.

Conclusion

There is no strong evidence that LPD impairs BC in patients with GFR ≤20 mL/min.

Department of Molecular and Clinical Medicine/Nephrology, Sahlgrenska Academy, Göteborg University, Gothenburg, Sweden

Corresponding Author InformationAddress reprint requests to Sintra Eyre, RD, Department of Molecular and Clinical Medicine/Nephrology, Sahlgrenska Academy, Göteborg University, Njurmottagningen, Vita Stråket 12, 1 Tr., SE-413 45 Gothenburg, Sweden.

PII: S1051-2276(07)00180-X

doi:10.1053/j.jrn.2007.08.006


View previous. 6 of 27 View next.